Join our Newsletter
Browse by Category
-
Most Read This Week
- Vical Incorporated announces results of herpes vaccine trial
- NIH studying newly emerging Staphylococcus aureus strain
- Japan deals with rubella outbreak
- University of Cincinnati researchers develop oral breast cancer vaccine
- CDC issues update on fungal meningitis outbreak
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: FDA
FDA panel approves four-strain flu vaccines
TweetA U.S. Food and Drug Administration advisory panel on vaccines gave its approval on Wednesday to quadrivalent, or four-strain, flu vaccines that may over time replace current three-strain vaccines. The panel gave its endorsement to a proposal by the World … Read More »
Egg-free vaccine receives FDA approval for distribution
TweetFlublok, an egg-free flu vaccine developed by the Meriden, Connecticut-based Protein Sciences Corporation, recently received approval for distribution by the U.S. Food and Drug Administration. The vaccine uses the small part of the virus needed for immunity and grows it … Read More »
FDA unveils global pharmacovigilance initiative
TweetThe U.S. Food and Drug Administration Center for Biologics Evaluation and Research recently launched a new initiative designed to support the Global Vaccine Safety Blueprint Project. The initiative, called “Global Regulatory Utilization of Vaccine Safety Surveillance,” was created under a … Read More »
Researchers develop vaccine for leishmaniasis
TweetScientists with the U.S. Food and Drug Administration’s Office of Blood Research and Review recently developed a live-attenuated vaccine for visceral leishmaniasis, a tropical disease that infects 12 million people annually. Visceral leishmaniasis is caused by the Leishmania protozoan and … Read More »
FDA say new TB treatment appears safe and effective
TweetThe U.S. Food and Drug Administration recently announced that a novel drug being developed to treat a drug-resistant form of tuberculosis appears safe. The FDA plans to review the Johnson & Johnson-developed drug bedaquiline for accelerated approval. The agency released … Read More »
FDA’s role in meningitis outbreak examined
TweetThe role of the U.S. Food and Drug Administration in regulating compound pharmacies has recently come under scrutiny following the outbreak of fungal meningitis that sickened nearly 500 people around the country. By law, compounding pharmacies like the New England … Read More »
FDA discusses REMS during webinar
Tweet The U.S. Food and Drug Administration held a webinar on Tuesday to discuss the implementation of a risk evaluation and mitigation strategy by physicians, pharmacists and patients. All medicines approved by the FDA go through assessments to determine their … Read More »
House holds contentious hearing with FDA commissioner
Tweet Lawmakers bickered consistently during a recent investigative hearing with U.S. Food and Drug Commissioner Margaret Hamburg over the fungal meningitis outbreak caused by contaminated steroid injections. The four hour House Subcommittee on Oversight and Investigations hearing was tense, with … Read More »